Compare · CBOE vs PPH
CBOE vs PPH
Side-by-side comparison of Cboe Global Markets, Inc. (CBOE) and VanEck Vectors Pharmaceutical ETF (PPH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CBOE and PPH operate in n/a (n/a), so they compete in similar markets.
- CBOE carries a market cap of $13.01B.
- CBOE has hit the wire 12 times in the past 4 weeks while PPH has been quiet.
- CBOE has more recent analyst coverage (25 ratings vs 0 for PPH).
Cboe Global Markets, Inc.
Cboe Global Markets, Inc., through its subsidiaries, operates as an options exchange worldwide. It operates through five segments: Options, North American Equities, Futures, European Equities, and Global FX. The Options segment trades in listed market indices. The North American Equities segment trades in listed U.S. and Canadian equities; and offers exchange-traded products (ETP) transaction and ETP listing services. The Futures segment trades in futures. The European Equities segment offers pan-European listed equities transaction services, ETPs, exchange-traded commodities, and international depository receipts, as well as ETP listings and clearing services. The Global FX segment provides institutional foreign exchange (FX) trading and non-deliverable forward FX transactions services. The company has strategic relationships with S&P Dow Jones Indices, LLC; FTSE International Limited; Frank Russell Company; MSCI Inc.; and DJI Opco, LLC. The company was formerly known as CBOE Holdings, Inc. and changed its name to Cboe Global Markets, Inc. in October 2017. Cboe Global Markets, Inc. was founded in 1973 and is headquartered in Chicago, Illinois.
VanEck Vectors Pharmaceutical ETF
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Latest CBOE
- Cboe To Hire Catherine Grover as Executive Vice President and Chief Human Resources Officer
- SEC Form 4 filed by Cboe Global Markets, Inc.
- Cboe Global Markets upgraded by Morgan Stanley with a new price target
- Cboe Global Markets Reports Trading Volume for September 2026
- Cboe Global Markets upgraded by TD Cowen with a new price target
- Wells Fargo initiated coverage on Cboe Global Markets with a new price target
- Cboe Global Markets upgraded by Goldman with a new price target
- Cboe and Robinhood Announce Planned Launch of New KPI Contracts, Further Expanding Prediction Market Offerings
- Cboe Global Markets, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
- Cboe Provides Additional Details Relating to Anticipated Financial Impacts of S&P DJI Licensing Agreement Extension
Latest PPH
- VanEck Announces Year-End Distributions for VanEck Equity ETFs
- Ozempic Maker Novo Nordisk Closes In On Lego As Denmark's Most Valuable Brand: Report
- Novo Nordisk's Game-Changer: FDA Approves Weight Loss Sensation Wegovy For Heart Health, Potential Insurance Coverage
- 11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yields
- Biden-Harris Administration Moves Forward with Medicare Drug Price Negotiations to Lower Prescription Drug Costs for People with Medicare